Funding for this research was provided by:
kuopion seudun hengityssäätiö
hengityssairauksien tutkimussäätiö
Article History
Received: 22 June 2021
Accepted: 6 September 2021
First Online: 15 September 2021
Declarations
:
: Heikki O Koskela has received funding for the present study from Kuopion Seudun Hengityssäätiö and Hengityssairauksien Tutkimussäätiö foundations, has been supported by AstraZeneca for attending a scientific meeting, and owns shares of a medical company Orion. Hanna M Nurmi has been supported by Boehringer-Ingelheim, Sanofi-Genzyme, and Chiesi for attending a scientific meeting and received payments for lectures from Boehringer-Ingelheim. Woo-Jung Song has received a research grant from MSD and consulting fees from MSD and AstraZeneca and received payment for lectures from MSD.
: The study was approved by the Ethics Committee of Kuopio University Hospital (289/2015).
: Written informed consent was sought from all participants.
: Not applicable.